Literature DB >> 26788205

Dermatofibrosarcoma protuberans with pit-like lesions: A case report and literature review.

Jinjing Jia1, Yan Zheng1, Xinyu Dong1, Xin Wang1, Jiao Yang1, Zhaoxia Ying1, Yongxian Wang1, Xinwu Niu1, Shengxiang Xiao1.   

Abstract

The present study describes a case of pit-like dermatofibrosarcoma protuberans (DFSP) with the clinical manifestations, histopathological features and criteria for diagnosis. The study also reviews the relevant literature in order to raise awareness among dermatologists with regard to the specific behavior of DFSP. A 27-year-old female presented with subcutaneous nodules on the left side of the neck that had been apparent for 5 years and which had gradually begun caving in during the last year. Histopathological examination revealed that the tumor was composed of a large number of spindle cells arranged in a whirlpool-like pattern. Immunohistochemical studies revealed positive staining for cluster of differentiation 34, vimentin and lysozyme, which could be used as diagnostic markers of DFSP. The patient was finally diagnosed with DFSP by pathological and immunohistochemical analyses. The DFSP was treated with an extended resection followed by adjacent skin repair. The patient responded well and no relapse occurred during the 8-month clinical follow-up. Thus, the current study describes a unique pit-like clinical manifestation of DFSP with typical immunohistochemical and pathological features. In addition, histopathological examination revealed a downward depression in the epidermis. Therefore, histopathological examination should be considered as an essential diagnostic tool for DFSP.

Entities:  

Keywords:  cluster of differentiation 34; eminence skin fibrosarcoma; lysozyme; pit-like; vimentin

Year:  2015        PMID: 26788205      PMCID: PMC4665724          DOI: 10.3892/ol.2015.3741

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

Review 1.  Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.

Authors:  C L Haycox; P B Odland; S M Olbricht; M Piepkorn
Journal:  J Am Acad Dermatol       Date:  1997-09       Impact factor: 11.527

2.  Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.

Authors:  W B Bowne; C R Antonescu; D H Leung; S C Katz; W G Hawkins; J M Woodruff; M F Brennan; J J Lewis
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

3.  Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.

Authors:  Reena Sachdev; Uma Sundram
Journal:  J Cutan Pathol       Date:  2006-05       Impact factor: 1.587

4.  Dermatofibrosarcoma protuberans with atrophic appearance at early stage of the tumor.

Authors:  Makiko Hanabusa; Riei Kamo; Teruichi Harada; Masamitsu Ishii
Journal:  J Dermatol       Date:  2007-05       Impact factor: 4.005

5.  A study on the prognostic value of clinical and surgical features of dermatofibrosarcoma protuberans in Korean patients.

Authors:  M Kim; C H Huh; K H Cho; S Cho
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-07-26       Impact factor: 6.166

6.  Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans.

Authors:  Victoria E Price; Jonathan A Fletcher; Maria Zielenska; William Cole; Sandra Viero; David E Manson; Mary Stuart; Alberto S Pappo
Journal:  Pediatr Blood Cancer       Date:  2005-05       Impact factor: 3.167

7.  Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.

Authors:  Philippe Saiag; Jean-Jacques Grob; Celeste Lebbe; Josep Malvehy; Veronique del Marmol; Hubert Pehamberger; Ketty Peris; Alexander Stratigos; Mark Middelton; Lars Basholt; Alessandro Testori; Claus Garbe
Journal:  Eur J Cancer       Date:  2015-07-16       Impact factor: 9.162

8.  Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans.

Authors:  L Martin; F Piette; P Blanc; L Mortier; M-F Avril; M M Delaunay; B Dréno; F Granel; F Mantoux; F Aubin; B Sassolas; H Adamski; S Dalac; C Pauwels; A Dompmartin; C Lok; E Estève; B Guillot
Journal:  Br J Dermatol       Date:  2005-11       Impact factor: 9.302

9.  Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate.

Authors:  Stefanos V Labropoulos; Jonathan A Fletcher; Andre M Oliveira; Savvas Papadopoulos; Evangelia D Razis
Journal:  Anticancer Drugs       Date:  2005-04       Impact factor: 2.248

10.  Dermatofibrosarcoma protuberans: a study of clinical, pathologic, genetic, and therapeutic features in Korean patients.

Authors:  Zhenlong Zheng; Junjei Piao; Ji-Hye Lee; Song-Ee Kim; Soo-Chan Kim; Kee Yang Chung; Mi Ryung Roh
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

View more
  2 in total

1.  Clinical Features, Pathological Findings and Treatment of Recurrent Dermatofibrosarcoma Protuberans.

Authors:  Yanan Li; Chuan Wang; Bo Xiang; Siyuan Chen; Li Li; Yi Ji
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207

2.  Clinicopathological features of fibrosarcomatous dermatofibrosarcoma protuberans and the construction of a back-propagation neural network recognition model.

Authors:  Yanan Li; Jiaqi Liang; Xuewen Xu; Xian Jiang; Chuan Wang; Siyuan Chen; Bo Xiang; Yi Ji
Journal:  Orphanet J Rare Dis       Date:  2021-01-26       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.